PPIs: Are the Risk Issues Being Overplayed?

Addressing recent inconclusive findings on the safety of proton-pump inhibitors, Dr. M. Brian Fennerty solicits feedback on how to communicate these risks to patients in the latest Gut Check blog post.

As PPIs are increasingly scrutinized for their safety in observational studies, more patients are inquiring whether they should take them. Pointing out the lack of established cause and effect in studies to date, Dr. M. Brian Fennerty asks, how should we communicate the risks and benefits of PPIs to our patients? Read Gut Check and contribute to the discussion.